Daniel Pharand

CX One, Inc. provides gold exploration services. The company is headquartered in Toronto, Canada.

C Level III, Inc. operates as a capital pool company. Currently, the company is in the process of identification and evaluation of assets or businesses for acquisition with a view to complete a qualifying transaction. C Level III was founded on June 10, 2011 and is headquartered in Toronto, Canada.

Innovatech Montréal, Inc. (IMI) is a Montréal-based venture capital company whose shares the Government of Québec holds.

Corautus Genetics Inc. is a biopharmaceutical company, which manufactures gene therapy products for the treatment of cardiac and vascular disease & peripheral vascular disease. It is located in Atlanta, GA.

Aurelian Resources, Inc. explores mines for gold, silver, and base metals. The company is headquartered in Toronto, Canada.

Hemodynamic Therapeutics, Inc. develops a novel small molecule combination therapy for obesity-related hypertension. The firm is developing its novel small molecule combination therapy (HTI-101) for obesity-related hypertension, one of the world's fastest growing cardiovascular disease markets. It has recently completed an initial Phase 2 clinical trial of HTI-101 in obese individuals with mild to moderate treatment-resistant hypertension. The company was founded in 2004 and is headquartered in Raleigh, NC.

Cancer Advances, Inc. develops treatment of gastrointestinal cancers. It also develops variety of immunomodulators which includes adaptive T-cells, therapeutic vaccines, and monoclonal antibodies for the treatment of gastric and pancreatic cancer. The company was founded in 2008 and is headquartered in Durham, NC.